Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Proteomics of cancer cell lines resistant to microtubule-stabilizing agents

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Acquired Resistance to a MET Antibody Can Be Overcome by the MET Antibody Mixture Sym015

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Longitudinal Increases in Serum Insulin-like Factor 3 and Testosterone Determined by LC-MS/MS in Pubertal Danish Boys

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Terror på hjernen

    Research output: Book/ReportBookCommunication

  5. Clinical proteomics: Insights from IGF-I

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

Despite the clinical success of microtubule-interacting agents (MIA), a significant challenge for oncologists is the inability to predict the response of individual patients with cancer to these drugs. In the present study, six cell lines were compared by 2D DIGE proteomics to investigate cellular resistance to the class of MIAs known as microtubule-stabilizing agents (MSA). The human lung cancer cell line A549 was compared with two drug-resistant daughter cell lines, a taxol-resistant cell line (AT12) and an epothilone B (EpoB)-resistant cell line (EpoB40). The ovarian cancer cell line Hey was compared with two drug-resistant daughter cell lines, an EpoB-resistant cell line (EpoB8) and an ixabepilone-resistant cell line (Ixab80). All 2D DIGE results were validated by Western blot analyses. A variety of cytoskeletal and cytoskeleton-associated proteins were differentially expressed in drug-resistant cells. Differential abundance of 14-3-3σ, galectin-1 and phosphorylation of stathmin are worthy of further studies as candidate predictive biomarkers for MSAs. This is especially true for galectin-1, a β-galactose-binding lectin that mediates tumor invasion and metastasis. Galectin-1 was greatly increased in EpoB- and ixabepilone-resistant cells and its suppression caused an increase in drug sensitivity in both drug-sensitive and -resistant Hey cells. Furthermore, the growth medium from resistant Hey cells contained higher levels of galectin-1, suggesting that galectin-1 could play a role in resistance to MSAs.

Original languageEnglish
JournalMolecular Cancer Therapeutics
Volume13
Issue number1
Pages (from-to)260-9
Number of pages10
ISSN1535-7163
DOIs
Publication statusPublished - Jan 2014

    Research areas

  • Cell Line, Tumor, Cytoskeletal Proteins, Drug Resistance, Neoplasm, Electrophoresis, Gel, Two-Dimensional, Epothilones, Gene Expression Regulation, Neoplastic, Humans, Microtubules, Neoplasm Proteins, Paclitaxel, Proteomics, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't

ID: 49496761